Search Results for « Chronic Musculoskeletal Pain »

Chronic pain is a common problem in rheumatology. A distinction is made between nociceptive pain and nociplastic pain. Nociceptive pain is, for example, mechanistically explained by persistent inflammation. Neuropathic pain is caused by nerve damage of various possible causes. In contrast, nociplastic pain is not due to tissue damage or a lesion in the somatosensory nervous system—at least not with the currently available techniques. Nociplastic pain is based on an altered perception of pain through modulation of stimulus processing. The concept of central sensitization, together with other neurobiological and psychosocial mechanisms, is considered to be the best explanation for such pain conditions. The syndrome of fibromyalgia (FM), considered to be due to central sensitization, plays a major role in rheumatology—both in terms of differential diagnosis and because the management of inflammatory rheumatic diseases can be made more difficult by the simultaneous presence of FM. During the coronavirus pandemic, persistent pain syndromes with similarities to FM were described following a COVID-19 infection. There is a growing scientific controversy as to whether the so-called long COVID syndrome (LCS) is a separate entity or just a variant of FM.

Abstract Background Chronic musculoskeletal pain (CMP) is a common condition treated by health care professionals including physiotherapists with increasing prevalence and causing disability and reduced quality of life. However, most of the treatments used are mainly biomedical yielding constrained outcomes and not in line with current clinical practice guidelines, which suggest the use of a biopsychosocial approach as the first-line treatment. A physiotherapy practice protocol based on neuro pain education, cognitive behaviour modification and self-management strategies is developed, which will be evaluated through a clinical trial and could transform the physiotherapy primary care practice according to the recommendations of the clinical practice guidelines. Methods A Randomised, single-centre clinical trial will be carried out to compare the effect of a Comprehensive chronic musculoskeletal Pain management (CCPM) which consists of 16 sessions weekly twice for 8 weeks Neuroscience Education program (4 sessions, 4 hrs)cognitive behaviour modification program(6 sessions,6 hrs),self-management strategies(4 sessions, 4 hrs) and revision of the program (2sessions, 2 hrs) along with usual care physiotherapy treatment for thrice weekly for 8weeks, with standardised physiotherapy thrice weekly for 8 weeks as control group. The study aims to evaluate the effect of CCPM intervention on central sensitisation, as well as on Fear avoidance, pain, disability, and pain self-efficacy The outcome variables will be measured at the beginning of the intervention and after 8 weeks Discussion The management of CMP pain can be improved by taking a multidisciplinary and holistic approach. However, the current healthcare system poses constraints to accessibility. It is necessary for physiotherapy practices to adopt a multi-dimensional pathway of treatment that considers all the bio-psychosocial factors during treatment sessions, rather than just following a bio-model pathway of management. Trial registration : CTRI/2023/05/053340 [Registered on: 31/05/2023] - Trial Registered Prospectively [https://ctri.nic.in/Clinicaltrials/main1.php?EncHid=96706.77723 ]